This study reported a similar incidence of MCMs following exposure to insulin (7.8%, n=5078) vs other antidiabetic agents: GLP-1 RAs (8.3% n=938), sodium-glucose co-transporter-2 inhibitors (SGLT2i) (7.0% n=335), sulfonylureas (9.7%, n=1362) and dipeptidyl peptidase 4 (DPP-4) inhibitors (6.1%, n=687)
Chen, Y.-Y
In contrast, GLP-1 alternatives build a long-term foundation for better health through natural GLP-1 activation
This has driven North America to account for 46.2% share of the Oral Obesity Drugs market in 2025
If approved, you can get Ozempic for free for up to 12 months
Improves cardiovascular function supplementation may improve lipid profile (lower LDL and TG, increase HDL), reduce homocysteine levels, and support heart muscle energy, especially in older adults